This kit is intended for the qualitative determination of antibodies against SARS-CoV-2 in human serum or plasma to support the diagnosis of COVID-19 disease.
Main Features:
- Separate detection of IgG, IgA, and IgM antibodies
- SARS-CoV-2 Nucleocapsid recombinant antigen
- Ideal complement to RT-PCR
- Ready-to-use controls
- Results in under 2 hours
- Assay procedure is easy to automate
- Works on several open ELISA systems (protocols available)
- CE-IVD marked
- Made in EU